Skip to main content

Table 1 Clinical characteristics of the study participants

From: Population-specific factors associated with fractional excretion of uric acid

 All
n = 1713
Eastern Polynesian
n = 483
Western Polynesian
n = 282
New Zealand European
n = 948
Age, mean (SD), years54.1 (17.5)50.0 (17.1)43.7 (16.5)59.4 (15.9)
Male sex, n (%)1227 (71.6)286 (59.2)179 (63.5)762 (80.4)
BMI, mean (SD), kg/m230.8 (6.8)32.6 (7.7)34.0 (6.5)28.9 (5.7)
 < 25 kg/m2, n (%)325 (19.0)65 (13.5)22 (7.8)238 (25.1)
 ≥ 25 kg/m2 and < 30 kg/m2, n (%)549 (32.0)122 (25.3)50 (17.7)377 (39.8)
 ≥ 30 kg/m2, n (%)839 (49.0)296 (61.3)210 (74.5)333 (35.1)
Current alcohol intake, n (%)1002 (58.5)208 (43.1%)101 (35.8)693 (73.1)
Gout, n (%)896 (52.3)206 (42.7)124 (44.0)566 (59.7)
Allopurinol use, n (%)709 (41.4)170 (35.2)109 (38.7)430 (45.4)
Diuretic use, n (%)322 (18.8)93 (19.3)38 (13.5)191 (20.1)
Serum creatinine, mean (SD), μmol/L101.1 (32.7)95.9 (29.1)100.9 (33.5)103.7 (33.9)
eGFR ≥ 60 mL/min/1.73 m2, n (%)1274 (74.4)380 (78.8)213 (76.6)657 (71.4)
Serum urate, mean (SD), mmol/L0.39 (0.11)0.38 (0.10)0.41 (0.11)0.38 (0.10)
Serum LDL-C, mean (SD), mmol/L2.84 (0.96)2.82 (0.96)2.8 (0.92)2.88 (0.97)
Serum triglyceride, mean (SD), mmol/L2.06 (1.43)2.12 (1.44)1.97 (1.31)2.06 (1.45)
FEUA, mean (SD), %5.48 (2.71)5.13 (2.70)4.70 (5.89)5.89 (2.73)
  1. BMI body mass index, eGFR estimated glomerular filtration rate, FEUA fractional excretion of uric acid, LDL-C low-density lipoprotein-cholesterol, SD standard deviation
\